NFE2L2 and neoplasm: Tumor immune-related gene expression signature and NRF2 pathway activation has been associated with efficacy of PD-1inhibitor combined with chemotherapy in lung caner.9Up to now, the above predictive biomarkers are tumor tissue-based.